Tag: biosimilars

29 Dec
Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers
Simon loxton

Lot-to-Lot Variability in Biologics and Biosimilars: What It Means for Patients and Providers

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, these drugs contain millions of slightly different protein versions in each batch. Learn how this variation is managed, why it doesn't affect safety, and what it means for patients and labs.

View More 12

recent posts

Antihistamines and Dementia Risk: What You Need to Know About Long-Term Use
Antihistamines and Dementia Risk: What You Need to Know About Long-Term Use

Published on: 12 Mar

How Pharmacists Communicate with Prescribers When Recommending Generic Medications
How Pharmacists Communicate with Prescribers When Recommending Generic Medications

Published on: 7 Mar

Shingles Vaccination: Who Should Get the Recombinant Zoster Vaccine
Shingles Vaccination: Who Should Get the Recombinant Zoster Vaccine

Published on: 14 Mar

Refractive Errors: How Myopia, Hyperopia, and Astigmatism Are Corrected Today
Refractive Errors: How Myopia, Hyperopia, and Astigmatism Are Corrected Today

Published on: 18 Mar

International Patent Expiration: Different Timelines Worldwide
International Patent Expiration: Different Timelines Worldwide

Published on: 11 Mar

categories

archives

tags